Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1982 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 486 |
| Marketable Securities | 277 |
| Other current assets | 51 |
| TOTAL | $814 |
| Non-Current Assets | |
| PPE Net | 30 |
| Investments And Advances | 1 |
| Other Non-Current Assets | 4 |
| TOTAL | $35 |
| Total Assets | $838 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 98 |
| TOTAL | $598 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $598 |
| Shareholders' Equity | |
| Common Shares | 70 |
| Retained earnings | -3,487 |
| TOTAL | $240 |
| Total Liabilities And Equity | $838 |